white papers

Streamlining Your Process Development Journey to GMP Manufacturing

Many CDMOs specialize in certain parts of the drug development lifecycle. Meanwhile, integrated turn-key offerings that support early-phase development through to commercial supply allow customers to partner with a single provider for the entire process or at any specific stage.

CDMOs, like Emergent, offering a global presence, operation across traditional and emerging therapeutic technology platforms, and GMP drug substance and GMP drug product manufacturing facilities are well-positioned to serve biopharmaceutical industry needs.

Download our white paper to learn more about the value and impact of partnering with an integrated CDMO in creating an efficient development services framework to achieve your drug substance and drug product manufacturing goals.

 

Finding the Right CDMO Partner for Tech Transfer

Regardless of where a drug candidate is in the development pipeline, performing a technology transfer (tech transfer) presents...

READ MORE

Using Viruses to Target Cancer Cells

Innovation in cancer therapeutics is moving at an accelerated pace. Advancements in the development and manufacturing of...

READ MORE

How CDMOs Can Support Nanoparticles for Gene Therapy, Immuno-Oncology and Vaccines

Nanoparticles have experienced increasing demand in recent years in biopharmaceutical formulations, owing to their utility for...

READ MORE